E. Palassini

发表

Response to imatinib plus sirolimus in advanced chordoma.

P. Casali, S. Pilotti, A. Marrari, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients.

Robin L. Jones, B. Alman, J. Blay, 2020, European journal of cancer.

Familial adenomatosis polyposis–related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis

Robin L. Jones, A. D. Dei Tos, P. Hohenberger, 2020, ESMO Open.

Tumor response to sunitinib malate observed in clear-cell sarcoma.

F. Grosso, P. Casali, T. Negri, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Management of serious complications in intra‐abdominal desmoid‐type fibromatosis

P. Casali, A. Gronchi, C. Morosi, 2021, Cancer reports.

Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case‐series analysis within the Italian Rare Cancer Network

L. Mariani, A. D. Dei Tos, P. Casali, 2020, Cancer.

Imatinib in advanced chordoma: A retrospective case series analysis.

P. Casali, S. Pilotti, A. Gronchi, 2015, European journal of cancer.

Sunitinib Malate and Figitumumab in Solitary Fibrous Tumor: Patterns and Molecular Bases of Tumor Response

U. Pastorino, P. Casali, M. Pierotti, 2010, Molecular Cancer Therapeutics.

Chordoma of the Mobile Spine and Sacrum: A Retrospective Analysis of a Series of Patients Surgically Treated at Two Referral Centers

L. Mariani, P. Casali, S. Pilotti, 2009, Annals of Surgical Oncology.

Phase II study on lapatinib in advanced EGFR-positive chordoma.

L. Mariani, P. Casali, T. Negri, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

MRP1 Overexpression Determines Poor Prognosis in Prospectively Treated Patients with Localized High-Risk Soft Tissue Sarcoma of Limbs and Trunk Wall: An ISG/GEIS Study

A. D. Dei Tos, P. Casali, S. Ferrari, 2013, Molecular Cancer Therapeutics.

Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis.

P. Casali, A. Gronchi, C. Morosi, 2015, European journal of cancer.

Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analyses

L. Mariani, O. Mir, A. Le Cesne, 2021, Breast Cancer Research and Treatment.

Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study

L. Mariani, P. Casali, S. Pilotti, 2018, Cancer.

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.

J. Blay, J. Coindre, P. Bruzzi, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

J. Blay, J. Coindre, P. Bruzzi, 2017, The Lancet. Oncology.

Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network.

A. D. Dei Tos, P. Casali, S. Pilotti, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG)†

Robin L. Jones, J. Blay, J. Sicklick, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database

F. Grosso, A. D. Dei Tos, P. Casali, 2016, Annals of Surgical Oncology.

Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.

A. Llombart‐Bosch, A. D. Dei Tos, P. Casali, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

High-grade Sarcomatous Overgrowth in Solitary Fibrous Tumors: A Clinicopathologic Study of 10 Cases

U. Pastorino, T. Negri, S. Pilotti, 2012, The American journal of surgical pathology.

Neoadjuvant treatment: a novel standard?

P. Casali, A. Gronchi, S. Stacchiotti, 2017, Current opinion in oncology.

Targeted therapy in colorectal cancer: do we know enough?

R. Labianca, M. Pantaleo, G. Biasco, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST).

P. Casali, S. Pilotti, A. Gronchi, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Dermatofibrosarcoma protuberans‐derived fibrosarcoma: Clinical history, biological profile and sensitivity to imatinib

P. Casali, T. Negri, S. Pilotti, 2011, International journal of cancer.

Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect.

P. Casali, T. Negri, S. Pilotti, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid‐type fibromatosis

P. Casali, A. Ferrari, A. Gronchi, 2021, Cancer medicine.

Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis

L. Mariani, P. Casali, A. Gronchi, 2017, Cancer journal.

Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics

C. Morosi, P. Casali, T. Negri, 2013, Clinical Cancer Research.

Sunitinib malate in solitary fibrous tumor (SFT).

A. D. Dei Tos, P. Casali, T. Negri, 2012 .

P. Hohenberger, A. D. Tos, B. Vincenzi, 2018 .

Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients.

S. Bonvalot, A. Cesne, O. Mir, 2015, European journal of cancer.

Response to chemotherapy of solitary fibrous tumour: a retrospective study.

L. Mariani, A. D. Dei Tos, P. Casali, 2013, European journal of cancer.

Sunitinib malate in solitary fibrous tumor (SFT).

A. D. Dei Tos, P. Casali, T. Negri, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Refining the Approach to Patients with Primary Soft Tissue Sarcoma of the Extremities and Trunk Wall: Outcome Improvement Over Time at a Single Institution

P. Casali, R. Miceli, A. Gronchi, 2022, Annals of Surgical Oncology.

ASO Visual Abstract: Refining the Approach to Patients with Primary Soft Tissue Sarcoma of the Extremities and Trunk Wall—Outcome Improvement over Time at a Single Institution

P. Casali, R. Miceli, A. Gronchi, 2022, Annals of Surgical Oncology.

Unplanned Excision of Extremity and Trunk Wall Soft Tissue Sarcoma: To Re-resect or Not to Re-resect?

P. Casali, R. Miceli, A. Gronchi, 2021, Annals of Surgical Oncology.

Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)

F. Grosso, A. D. Dei Tos, P. Casali, 2015, Clinical Cancer Research.

1450PSYSTEMIC THERAPY IN PERIVASCULAR EPITHELIOID CELL TUMORS (PECOMA).

A. D. Dei Tos, P. Casali, A. Marrari, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study on lapatinib in advanced EGFR-positive chordoma.

L. Mariani, P. Casali, T. Negri, 2013 .

High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial.

A. D. Dei Tos, P. Casali, S. Ferrari, 2018, European journal of cancer.

Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study.

Robin L. Jones, J. Blay, M. Toulmonde, 2022, European journal of cancer.

Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial

J. Blay, J. Coindre, P. Bruzzi, 2021, Cancer.

Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall.

A. D. Dei Tos, P. Casali, S. Ferrari, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report

P. Casali, T. Negri, S. Pilotti, 2015, BMC Cancer.

Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report

P. Casali, T. Negri, S. Pilotti, 2015, BMC Cancer.

Clear cell sarcoma (CCR): Clinical behavior and response to chemotherapy.

P. Casali, T. Negri, S. Pilotti, 2010 .

Vascular resection en-bloc with tumor removal and graft reconstruction is safe and effective in soft tissue sarcoma (STS) of the extremities and retroperitoneum.

P. Casali, A. Gronchi, C. Morosi, 2016, Surgical oncology.

Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Final results of a randomized clinical trial from the Italian Sarcoma Group, the Spanish Sarcoma Group (GEIS), the French Sarcoma Group (FSG), and the Polish Sarcoma Group (PSG).

J. Blay, P. Bruzzi, P. Casali, 2019, Journal of Clinical Oncology.

β‐Catenin in desmoid‐type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expression

L. De Cecco, S. Canevari, S. Pilotti, 2017, Molecular oncology.

P. Hrelia, P. Casali, J. L. Bermejo, 2014, European Journal of Human Genetics.

Sirolimus in advanced hemangioendothelioma.

P. Casali, S. Pilotti, A. D. Tos, 2013 .

Evaluation of the antitumor activity of sunitinib malate (SM) in solitary fibrous tumor (SFT).

U. Pastorino, P. Casali, T. Negri, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A prospective observational study of Active surveillance in primary desmoid fibromatosis.

L. Mariani, P. Casali, A. Gronchi, 2022, Clinical Cancer Research.

Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy.

P. Hrelia, P. Casali, G. Cantelli-forti, 2013, Pharmacological research.

Sunitinib malate in advanced alveolar soft part sarcoma (ASPS): A final update after the closure of the named use program.

P. Casali, T. Negri, S. Pilotti, 2015 .

Sunitinib malate (SM) in alveolar soft part sarcoma (ASPS).

P. Casali, T. Negri, S. Pilotti, 2010 .

Novel intra‐genic large deletions of CTNNB1 gene identified in WT desmoid‐type fibromatosis

A. Gronchi, S. Stacchiotti, F. Perrone, 2018, Genes, chromosomes & cancer.

Response to imatinib plus sirolimus in advanced chordoma.

P. Casali, S. Pilotti, A. Marrari, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wall

P. Casali, R. Miceli, A. Gronchi, 2023, Cancer.

Current management of familial adenomatous polyposis

M. T. Ricci, S. Signoroni, M. Vitellaro, 2024, Expert review of anticancer therapy.